Call for project proposals
Are you involved in research in the field of addiction medicine? Do you have a research question that SAMMSU data could answer? We are happy to receive your project proposal. Please find the form for project proposals below. Fill it in and send it to [email protected].
| SAMMSU Project Proposal |
Publications
Michael Lütolf et al. 2025: Characteristics and comorbidities of patients on opioid agonist therapy in Switzerland: a descriptive analysis of the nationwide SAMMSU cohort: Drug and Alcohol Dependence Reports (in print).
The publication is accessible here.
The publication is accessible here.
Posters 2014 - 2026
Castro et al. 2026: «Treatment as prevention » contre le VIH et le VHC chez les patients sous traitement agoniste opioïde (TAO) suivis dans la cohorte SAMMSU en Suisse: Poster at the AFRAVIH Conference in Lausanne, May 2026.
| afravih_2026__pb226_castro.pdf |
Hijazi et al. 2025: Hepatits B and D Testing and Prevalence in a Swiss National Cohort of People on Opioid Agonist Therapy: Poster at the INHSU Conference in Cape Town, October 2025.
| poster_inshu2025_hepatitis_oat.pdf |
Bregenzer et al. 2025: Trends of opioid agonist therapies and QT prolongation in the Swiss Association for the Medical Management in Substance Users (SAMMSU) cohort 2013-2024: Poster at the INHSU Conference in Cape Town, October 2025.
| poster_inhsu2025_oat_qt_prolongation.pdf |
Bregenzer et al. 2025: Schweizer OAT Kohorte (SAMMSU): Beschreibung der Opioid-Agonisten-Therapie: Poster am Interdisziplinären Kongress für Suchtmedizin in München, Juli
2025.
2025.
| poster_münchen2025_sammsu_oat.pdf |
Bregenzer et al. 2025: Schweizer OAT-Kohorte (SAMMSU): Late-Presentation von Hepatitis C seit 2017: Poster am Interdisziplinären Kongress für Suchtmedizin in München, Juli 2025.
| poster_münchen2025_hcv_lp_de.pdf |
Hijazi et al. 2025: Hepatits B and D Testing and Prevalence in a Swiss National Cohort of People on Opioid Agonist Therapy: Poster at the INHSU Conference in Cape Town, October 2025.
| Bregenzer et al. inhsu2024_oat.pdf |
Bregenzer et al. 2024: HCV late presentation (severe fibrosis/cirrhosis at first HCV therapy or first HCV diagnosis) in the Swiss Association for the Medical Management in Substance Users (SAMMSU) cohort since 2017: Poster at the INHSU Conference in Athens, October 2024.
| Bregenzer et al. inhsu2024_late_presenters.pdf |
Bregenzer et al. 2024: HIV and HCV cascade, RNA prevalence and new diagnoses in opioid agonist therapy (OAT) patients
from the SAMMSU-cohort, Switzerland: Poster at the International AIDS conference in Munich, 2024.
from the SAMMSU-cohort, Switzerland: Poster at the International AIDS conference in Munich, 2024.
| Bregenzer et al. 2024_HIV_HCV.pdf |
Bregenzer et al. 2023: Current prevalence of and risk factors for liver cirrhosis in opioid agonist therapy patients of the SAMMSU cohort after 5 years of unrestricted DAA access, Poster at the INHSU Conference, Geneva, 2023.
| bregenzer_et_al_inhsu2023_liver_cirrhosis.pdf |
Bregenzer et al. 2023: Occurrence and outcome of hepatitis C reinfections in opioid agonist therapy patients of the SAMMSU cohort, Poster at the INHSU Conference, Geneva, 2023.
| bregenzer_et_al_inhsu2023_reinfections.pdf |
Moriggia et al. 2022: Late presentation of chronic hepatitis C in a Swiss cohort of people in opioid agonist therapy.
| Moriggia A. et al. 2022.pdf |
Castro et al. 2022: Mental disorders and hepatitis C prevalence in people in opioid agonist therapy followed at the SAMMSU cohort, Switzerland.
| Castro E. et al. INHSU 2022.pdf |
Bregenzer et al. 2019: The HIV and HCV cascade in Swiss opioid agonist treatment (OAT) patients the SAMMSU cohort.
| Bregenzer et al. EACS 2019.pdf |
Bregenzer et al. 2018: Feasibility, outcome and uptake of IFN-based and IFN-free DAA HCV-treatment in OST patients in Switzerland - The SAMMSU-Cohort.
| Bregenzer A. et al. INHSU 2018 |
Moriggia et al. 2017: Barriers to widespread hepatitis C treatment among people who inject drugs: data from the SAMMSU cohort.
| Moriggia A. et al. INHSU 2017 |
Moriggia et al. 2016: Prospective data on people who use drugs in Switzerland: the SAMMSU cohort.
| Moriggia A. et al. INHSU 2016 |
Castro et al.2015: Swiss data on hepatitis C treatment in people who use drugs: the SAMMSU cohort.
| Castro E. et al: Look back study INHSU 2015 |